Cerapro® MED is a novel, non-steroidal cream for the
treatment of atopic dermatitis. Given the widespread avoidance of topical
corticosteroids in young children, there is a significant unmet need for
effective, non-steroidal alternatives.
As a first-in-class, skin pH-lowering therapy protected by
patents across the US, EU, and UK, Cerapro® MED directly targets skin pH – the
master key in skin barrier homeostasis – to address a core pathogenesis of the
condition.
Clinically developed and backed by published scientific
evidence, Cerapro® MED is approved for the treatment of atopic dermatitis,
establishing it as a highly differentiated, scientifically validated innovation
in dermatology.
